Clinical Trial Update: An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease [Phase 2]

View source ↗

Summary

Open-label rollover Phase 2 trial evaluating the efficacy and safety of AMG 732 in participants with Thyroid Eye Disease; the study status is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• AMG 732

Snippet

Sponsor: Amgen | Conditions: Thyroid Eye Disease | Phase 2 | Status: NOT_YET_RECRUITING